The High Court has mandated the implementation of effective measures to curb the escalation of medicine prices across the nation. The Director General of the Directorate General of Drug Administration, along with other relevant parties, has been instructed to execute the court's directive.

Additionally, the court has issued a rule, calling upon the concerned authorities to provide explanations for their failure to prevent the medicine price surge, which could potentially be deemed illegal.

Furthermore, the court has ordered a halt to the sale of unapproved drugs imported from overseas.

The High Court bench, comprising Justice Mustafa Zaman Islam and Justice Md Atabullah, issued these directives following a writ petition. The petition, filed by the Consumer Association of Bangladesh (CAB), referenced a news report indicating a substantial increase in medicine prices ranging from 7% to 140% over a two-week period.

The report highlighted that numerous pharmaceutical companies in the country have persistently raised the prices of their manufactured medicines over the past two months. This surge has seen prices of at least 50 types of medicines soar by 20% to 140%.